A2A:MILA2A S.p.A. Analysis
Data as of 2026-05-18 - not real-time
€2.18
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
A2A (A2A.MI) is trading at €2.178, notably below its DCF fair value of €2.60, implying roughly a 28% upside. The stock also enjoys a low PE of 9 versus an industry average of 21, a solid dividend yield of 4.57% with a comfortable payout ratio of 42%, and a revenue growth of 14.7% YoY. Technicals show the price hovering just above the support at €2.129, an RSI of 28 indicating oversold conditions, and a bearish MACD divergence, while volume is on the rise, suggesting buying interest may be building.
Fundamentally, A2A's cash generation is healthy (free cash flow ~€0.56 bn) and its balance sheet, though leveraged, is manageable given the utility sector’s stable cash flows. The low beta (~0.26) and modest 30‑day volatility (~24%) point to limited price swings, while regulatory exposure remains typical for utilities. Overall, the combination of undervaluation, attractive yield, and improving momentum supports a positive outlook.
Fundamentally, A2A's cash generation is healthy (free cash flow ~€0.56 bn) and its balance sheet, though leveraged, is manageable given the utility sector’s stable cash flows. The low beta (~0.26) and modest 30‑day volatility (~24%) point to limited price swings, while regulatory exposure remains typical for utilities. Overall, the combination of undervaluation, attractive yield, and improving momentum supports a positive outlook.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Oversold RSI (~28) signaling potential bounce
- Price below DCF fair value with ~28% upside
- Increasing volume indicating renewed interest
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued multiples (PE 9 vs industry 21)
- Strong cash flow and sustainable dividend yield
- Robust revenue growth (~15% YoY) supporting earnings expansion
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable utility business with regulated cash flows
- Long‑term dividend sustainability
- Potential regulatory and macro‑economic headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth14.70%
Profit Margin4.86%
P/E Ratio9.1
ROE11.48%
ROA3.44%
Debt/Equity109.90
P/B Ratio1.3
Op. Cash Flow€1.7B
Free Cash Flow€560.9M
Industry P/E21.3
Technical Analysis
TrendNeutral
RSI28.7
Support€2.13
Resistance€2.43
MA 20€2.35
MA 50€2.39
MA 200€2.35
MACDBearish
VolumeIncreasing
Fear & Greed Index87.13
Valuation
Fair Value€2.60
Target Price€2.81
Upside/Downside28.82%
GradeUndervalued
TypeBlend
Dividend Yield4.57%
Risk Assessment
Beta0.26
Volatility24.30%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.